Apparently, the results confirm that EWI‐2 indeed contributes to the suppressed activation of EGFR phosphorylation and suggest that the EWI‐2 is likely required for the suppression of EGFR‐mediated cancer cell motility. This evidence concerns the gene EGFR and cancer.